Lumibird SA (LBIRD) AI Stock Analysis

• Market Cap: €452.70M
• Dividend Yield: N/A
• Average Volume (3M): 32.82K
• Price to Earnings (P/E): 41.9
• Beta (1Y): 0.63
• Revenue Growth: 5.66%
• EPS Growth: 66.79%
• Country: FR
• Employees: 1,027
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 0.22
• Shares Outstanding: 22,466,883
• 10 Day Avg. Volume: 22,637
• 30 Day Avg. Volume: 32,817
• PEG Ratio: -1.93
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.98
• P/FCF Ratio: 18.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €16.50
• Price Target Upside: -19.12% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 57 Neutral
• Price Target: €16.50 ▼(-19.12% Downside)

Lumibird SA's overall stock score is primarily influenced by its strong operational efficiency and moderate financial stability. However, bearish technical indicators and a high P/E ratio suggest caution. The lack of earnings call data and corporate events limits additional insights.

Lumibird SA Business Overview & Revenue Model

Company Description

Lumibird SA (LBIRD) is a leading player in the photonics sector, specializing in the design and manufacture of innovative laser systems and solutions. The company operates primarily in the industrial, medical, and defense markets, offering a diverse range of products including laser sources, systems for material processing, and medical lasers. With a strong focus on research and development, Lumibird continuously seeks to enhance its technological capabilities and expand its product offerings to meet the evolving needs of its customers.

How the Company Makes Money

Lumibird generates revenue through multiple key streams, primarily from the sale of its laser systems and components across various sectors. The company earns significant income from long-term contracts with industrial clients, where it provides tailored laser solutions for applications like cutting, welding, and marking. Additionally, Lumibird has established partnerships with medical device manufacturers, supplying advanced laser technology for surgical and therapeutic applications. Other revenue streams include maintenance services, training, and consulting for clients, which further solidify its earnings. The company also benefits from government contracts and research grants aimed at advancing photonics technology, contributing to its overall financial performance.

Lumibird SA Financial Statement Overview

Summary

Lumibird SA demonstrates strong operational efficiency and moderate financial stability. The income statement indicates pressure on margins, while the balance sheet maintains a healthy equity ratio. Positive cash flows highlight the company's ability to support operations and growth.

Income Statement

Lumibird SA's income statement shows a stable revenue base with a slight increase from 2023 to 2024. Gross profit margin has slightly decreased over the years, indicating rising costs or pricing pressure. The net profit margin has declined from 2023 to 2024, suggesting challenges in maintaining profitability. However, EBIT and EBITDA margins remain decent, reflecting operational efficiency in managing expenses.

Balance Sheet

The balance sheet of Lumibird SA reflects moderate financial stability. The debt-to-equity ratio is manageable, though it has slightly increased over the years, indicating a rising reliance on debt. The equity ratio is stable, ensuring a sound capital structure. Return on equity has decreased, which may concern investors regarding the effectiveness of equity use.

Cash Flow

Lumibird SA's cash flow statement indicates strong operating cash flows, showing the company's ability to generate cash from its core operations. The free cash flow has improved from previous years but remains a concern due to high capital expenditures. The operating cash flow to net income ratio is robust, reflecting efficient cash generation relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	217.63M	210.06M	206.55M	194.29M	162.47M	129.50M
Gross Profit	20.78M	16.06M	128.11M	15.36M	18.49M	13.24M
EBITDA	39.19M	31.03M	27.31M	32.09M	31.81M	17.96M
Net Income	10.73M	5.70M	7.13M	11.35M	13.86M	5.64M
Balance Sheet
Total Assets	435.94M	429.80M	405.25M	372.04M	347.62M	305.43M
Cash, Cash Equivalents and Short-Term Investments	71.26M	71.14M	56.20M	61.68M	97.13M	80.33M
Total Debt	165.85M	161.06M	145.08M	114.18M	112.03M	88.31M
Total Liabilities	236.13M	231.79M	211.95M	178.61M	166.29M	141.35M
Stockholders Equity	196.03M	198.01M	193.30M	193.44M	181.33M	164.09M
Cash Flow
Free Cash Flow	5.13M	11.41M	-4.89M	-28.02M	6.47M	747.00K
Operating Cash Flow	27.26M	34.37M	20.67M	1.43M	26.57M	13.12M
Investing Cash Flow	-21.64M	-22.84M	-46.15M	-29.34M	-28.63M	-67.14M
Financing Cash Flow	2.13M	3.39M	21.69M	-7.89M	18.20M	84.76M

Lumibird SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.40
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LBIRD, the sentiment is Positive. The current price of 20.4 is above the 20-day moving average (MA) of 20.33, above the 50-day MA of 18.83, and above the 200-day MA of 14.08, indicating a bullish trend. The MACD of 0.43 indicates Negative momentum. The RSI at 65.73 is Neutral, neither overbought nor oversold. The STOCH value of 90.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LBIRD.

Lumibird SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALDLT	68 Neutral	€332.16M	11.20	11.71%	2.26%	-1.89%	-3.39%
EXE	67 Neutral	€242.28M	8.67	6.23%	3.22%	-4.89%	-35.10%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
LBIRD	57 Neutral	€452.70M	41.87	5.51%	―	5.66%	66.79%